Esperion Therapeutics, Inc.·4

Nov 20, 4:10 PM ET

Warren Eric 4

4 · Esperion Therapeutics, Inc. · Filed Nov 20, 2024

Insider Transaction Report

Form 4
Period: 2024-11-19
Warren Eric
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2024-11-19$2.17/sh197$427162,355 total
Footnotes (1)
  • [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.

Documents

2 files